Skip to main navigation
Skip to main content
Utility Nav Header
Contact
Twitter
LinkedIn
Main navigation
About
Our Focus
CEO Video
Leadership
Board of Directors
Scientific Advisory Board
Corporate Responsibility
Corporate Governance
Diversity & Inclusion
Corporate Giving
Our Science
Our Approach
Pipeline
Pipeline
Repotrectinib
Elzovantinib (TPX-0022)
TPX-0046
TPX-0131
Publications & Presentations
Clinical Trials
Company Trials
Compassionate Use
Investigator Sponsored Research
Investors
Overview
Press Releases
Events
Presentations
SEC Filings
Quarterly Results
Stock Information
Stock Quote & Chart
Analyst Coverage
Corporate Governance
Documents & Charters
Board of Directors
Leadership
Committee Composition
Investor Contact
Email Alerts
Careers
Vision, Mission & Values
Our Culture
Diversity & Inclusion
Opportunities
Our Hiring Process
Benefits
Event Details
41st Annual Canaccord Genuity Growth Conference
Aug 11, 2021 at 4:00 PM EDT
Listen to the webcast
